GlassScriptPhysician profile
Justin Daniel Needham
NPI 1699923516
$3,131.86
in general payments reported to CMS, 2019-2025
26 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $230 · 2021: $463 · 2022: $560 · 2023: $770 · 2024: $654 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,588 · Gift: $36.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,587.93 |
| Gift | $36.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $731.94 | 2021-2025 | Argos, Hydrus Microstent, Clareon |
| Biotissue Holdings INC. | $351.74 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $314.48 | 2022-2024 | Envista Mx60 Iol, Miebo, Ic-8 Apthera Iol |
| Carl Zeiss Meditec USA, INC. | $311.59 | 2022-2025 | Visumax, Mel 90, Iolmaster 700 |
| Carl Zeiss Meditec, INC. | $308.37 | 2019-2023 | Callisto Eye, Artevo 800, Veracity Surgical |
| Abbvie INC. | $161.34 | 2022-2024 | |
| Oyster Point Pharma, INC. | $159.54 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $139.82 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $99.66 | 2020-2022 | |
| New World Medical,INC. | $67.50 | 2019 | |
| Akorn Operating Company LLC | $62.90 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $55.68 | 2019-2025 | Tecnis Iol, Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $46.47 | 2020-2023 | Cequa |
| Aerie Pharmaceuticals, INC. | $40.13 | 2021 | |
| Akorn, INC. | $35.73 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $34.59 | 2021 | |
| Eyepoint US, INC. | $28.30 | 2020 | |
| Staar Surgical Company | $25.31 | 2019 | |
| Merz Pharmaceuticals, LLC | $25.07 | 2023 | Xeomin |
| Ivantis, INC | $20.98 | 2021 | |
| Kala Pharmaceuticals, INC. | $20.02 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rxsight INC | $19.36 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.68 | 2020 | |
| Thea Pharma INC. | $17.14 | 2024 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $17.12 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Needham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.